(VIANEWS) – The NASDAQ ended the session with Viking Therapeutics (VKTX) rising 16.82% to $80.83 on Tuesday while NASDAQ dropped 0.42% to $16,315.70. Viking Therapeutics’s last close was $69.19, 30.4% under its 52-week high of $99.41. About Viking Therapeutics Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic…
(VIANEWS) – The NASDAQ ended the session with SNDL Inc. (SNDL) jumping 13.87% to $1.97 on Tuesday while NASDAQ fell 0.42% to $16,315.70. SNDL Inc.’s last close was $1.73, 26.69% under its 52-week high of $2.36. About SNDL Inc. SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company…
(VIANEWS) – The NASDAQ ended the session with Rumble jumping 15.42% to $8.61 on Tuesday, after two successive sessions in a row of gains. NASDAQ slid 0.42% to $16,315.70, following the last session’s downward trend on what was a somewhat down trend trading session today. Rumble’s last close was $7.46, 33.69% under its 52-week high…
(VIANEWS) – The NASDAQ ended the session with Nikola jumping 9.28% to $0.81 on Tuesday, after five consecutive sessions in a row of gains. NASDAQ fell 0.42% to $16,315.70, following the last session’s downward trend on what was a somewhat negative trend trading session today. Nikola’s last close was $0.74, 79.95% below its 52-week high…
(VIANEWS) – The NASDAQ ended the session with Canopy Growth rising 16.61% to $7.23 on Tuesday, after two sequential sessions in a row of losses. NASDAQ slid 0.42% to $16,315.70, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today. Canopy Growth’s last close was $6.20, 71.03% under its…
(VIANEWS) – Sabre Corporation (SABR) shares experienced a sharp 17.26% gain over five sessions from EUR2.03 to EUR2.36 on Tuesday – this came after two consecutive days of losses and following an upward trend in previous sessions. Meanwhile, the NASDAQ index rose 0.25% after experiencing an initial downward trend in previous session; Sabre Corporation closed…
(VIANEWS) – FibroGen (NASDAQ: FGEN) experienced an unprecedented 30.98% surge over the past 21 sessions, rising from EUR1.98 on February 28th to EUR2.59 at 12:57 EST Tuesday at 12:57, marking five straight sessions of gains. Meanwhile, NASDAQ is also showing signs of life with its Index currently up 0.39% at EUR16,447.96; FibroGen’s last close price…
About Viking Therapeutics Viking Therapeutics is a clinical-stage biopharmaceutical company, focused on the creation of innovative treatments for metabolic and endocrine conditions. VK2809, their lead drug candidate, is a tissue and receptor subtype selective agonist of thyroid hormone receptor beta currently in Phase IIb clinical trials for treating nonalcoholic steatohepatitis and nonalcoholic fatty liver disease…
(VIANEWS) – The NASDAQ opens in less than hour and Viking Therapeutics‘s pre-market value is already 14.54% up. Viking Therapeutics’s last close was $69.19, 30.4% under its 52-week high of $99.41. The last session, NASDAQ finished with Viking Therapeutics (VKTX) dropping 0.52% to $69.19. NASDAQ slid 0.27% to $16,384.47, following the last session’s downward trend…
(VIANEWS) – The NASDAQ opens in less than hour and TherapeuticsMD‘s pre-market value is already 4.8% up. TherapeuticsMD’s last close was $2.29, 51.48% under its 52-week high of $4.72. The last session, NASDAQ finished with TherapeuticsMD (TXMD) sliding 0% to $2.29. NASDAQ dropped 0.27% to $16,384.47, following the last session’s downward trend on what was…
